These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16919047)

  • 21. Antiretroviral therapy affects the composition of weight loss in HIV infection: implications for clinical nutrition.
    Maia BS; Engelson ES; Wang J; Kotler DP
    Clin Nutr; 2005 Dec; 24(6):971-8. PubMed ID: 16095765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy.
    Blümer RM; van Vonderen MG; Sutinen J; Hassink E; Ackermans M; van Agtmael MA; Yki-Jarvinen H; Danner SA; Reiss P; Sauerwein HP
    AIDS; 2008 Jan; 22(2):227-36. PubMed ID: 18097225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
    Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.
    Martos-Moreno GÁ; Kratzsch J; Körner A; Barrios V; Hawkins F; Kiess W; Argente J
    Int J Obes (Lond); 2011 Oct; 35(10):1355-62. PubMed ID: 21266955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating visfatin level is correlated with inflammation, but not with insulin resistance.
    Oki K; Yamane K; Kamei N; Nojima H; Kohno N
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum leptin and bone metabolism in HIV patients treated with highly active antiretroviral therapy.
    Madeddu G; Spanu A; Chessa F; Calia GM; Lovigu C; Mannazzu M; Falchi A; Sanna D; Mura MS; Madeddu G
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):290-301. PubMed ID: 18596668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels.
    Lihn AS; Richelsen B; Pedersen SB; Haugaard SB; Rathje GS; Madsbad S; Andersen O
    Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1072-80. PubMed ID: 12876073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
    Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
    Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
    Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC
    Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased visfatin concentrations in women with gestational diabetes mellitus.
    Krzyzanowska K; Krugluger W; Mittermayer F; Rahman R; Haider D; Shnawa N; Schernthaner G
    Clin Sci (Lond); 2006 May; 110(5):605-9. PubMed ID: 16489932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial.
    Sutinen J; Walker UA; Sevastianova K; Klinker H; Häkkinen AM; Ristola M; Yki-Järvinen H
    Antivir Ther; 2007; 12(1):97-105. PubMed ID: 17503753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy.
    Giralt M; Domingo P; Guallar JP; Rodriguez de la Concepción ML; Alegre M; Domingo JC; Villarroya F
    Antivir Ther; 2006; 11(6):729-40. PubMed ID: 17310817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men.
    Peng XD; Xie H; Zhao Q; Wu XP; Sun ZQ; Liao EY
    Clin Chim Acta; 2008 Jan; 387(1-2):31-5. PubMed ID: 17884030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.
    Stefan N; Hennige AM; Staiger H; Machann J; Schick F; Schleicher E; Fritsche A; Häring HU
    Diabetes Care; 2007 May; 30(5):1173-8. PubMed ID: 17259477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.
    Bolland MJ; Grey AB; Horne AM; Briggs SE; Thomas MG; Ellis-Pegler RB; Woodhouse AF; Gamble GD; Reid IR
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):270-5. PubMed ID: 17547686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proinflammatory markers, insulin sensitivity, and cardiometabolic risk factors in treated HIV infection.
    Samaras K; Gan SK; Peake PW; Carr A; Campbell LV
    Obesity (Silver Spring); 2009 Jan; 17(1):53-9. PubMed ID: 19008869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy.
    Johnson JA; Albu JB; Engelson ES; Fried SK; Inada Y; Ionescu G; Kotler DP
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E261-71. PubMed ID: 14532165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leptin, adiponectin, visfatin and retinol-binding protein-4 - mediators of comorbidities in patients with psoriasis?
    Gerdes S; Osadtschy S; Rostami-Yazdi M; Buhles N; Weichenthal M; Mrowietz U
    Exp Dermatol; 2012 Jan; 21(1):43-7. PubMed ID: 22151390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects.
    Albert SG; Haas MJ; Mooradian AD
    Growth Horm IGF Res; 2007 Feb; 17(1):19-25. PubMed ID: 17118687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance.
    Fernández-Real JM; Moreno JM; Chico B; López-Bermejo A; Ricart W
    Diabetes Care; 2007 Mar; 30(3):616-21. PubMed ID: 17327330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.